Cardiovascular drugs for pharmaceuticals

Pain relievers and fever reducers such as paracetamol, metamizole, tramadol and aspirin.

Non-steroidal anti-inflammatory drugs and antirheumatics such as ibuprofen, diclofenac and naproxen.

Penicillins, cephalosporins, macrolides, fluoroquinolones, tetracyclines and antituberculosis drugs.

Antiretrovirals, anti-herpes, anti-hepatitis and influenza drugs such as acyclovir, tenofovir and oseltamivir.

Azole, allylamine, echinocandin and polyene antifungal drugs such as fluconazole and terbinafine.

ACE inhibitors, sartans, calcium channel blockers, beta blockers and diuretics.

Metformin, sulfonylureas, gliptins, gliflozins and other glucose-lowering drugs.

Cytotoxic agents, kinase inhibitors, hormonal cancer therapies and other oncology APIs.

Antidepressants, antipsychotics, anticonvulsants, anxiolytics, hypnotics and anesthetics.

Antihistamines, bronchodilators, antiasthmatics, decongestants and cough remedies.

Corticosteroids, estrogens, progestins, androgens and thyroid hormones.

Vitamins and nutraceutical actives for medicines and dietary supplements.

Fillers, binders, disintegrants, lubricants, coatings, solvents and preservatives for dosage forms.

Key starting materials and advanced intermediates for API synthesis.